Pyrrolotriazine derivatives for treating kit-and pdgframediated diseases
PH12021552568B1Active Publication Date: 2026-11-06BLUEPRINT MEDICINES CORP
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12021552568
- Authority / Receiving Office
- PH · PH
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-10-07
- Publication Date
- 2026-11-06
- Estimated Expiration
- 2041-10-07
Abstract
The present disclosure provides compounds of Formula I, pharmaceutical salts thereof, and / or solvates of any of the foregoing, which are useful for treating diseases and conditions related to mutant KIT and PDGFRα and present an advantageously non-brain penetrant profile for treating diseases and conditions related to mutant KIT and PDGFRα. The present disclosure also provides methods for treating gastrointestinal stromal tumors and systemic mastocytosis.
Need to check novelty before this filing date? Find Prior Art
